Hydroxy isothiocyanates, especially 2-(4-hydroxyphenyl)ethyl isothiocyanate (hITC), were examined for antimicrobial synergism with streptomycin (SM) against Escherichia coli. On the course of those experiments, a peculiar suppression of SM by a low concentration of hITC was observed, besides the antibacterial synergism of hITC with SM. Further, bactericidal activity of SM in physiological saline was reduced by addition of hITC. Time course experiments proved that the antagonistic eŠect of hITC occurred in an early stage after exposure of bacterial cells to SM.
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Key words: hydroxy isothiocyanate; 2-(4-hydroxyphenyl)ethyl isothiocyanate; antagonism; synergism; streptomycin Naturally occurring and synthetic isothiocyanates (ITCs) have been studied extensively for their antibacterial and W or antifungal activities. 1) In a previous paper, we reported that a novel hydroxy ITC 2-(4-hydroxyphenyl)ethyl ITC(hITC) synthesized from tyramine, showed strong antifungal and antibacterial activities, and that a possible target of the ITC compounds might be the cellular sulfhydryl group.
2) In addition we found that hITC exerted antimicrobial synergism with aminoglycoside antibiotics such as streptomycin, in glucose-containing medium. 3) In further experiments on antimicrobial synergism with aminoglycoside antibiotics against Escherichia coli, a peculiar antagonism was observed at a lower concentration range of hITC. This report is concerned with this curious antagonism between hITC and SM.
Streptomycin sulfate (SM) was from commercial sources, and hITC was synthesized from tyramine as previously reported. 2, 4, 5) Upon incubation in M9 with SM, hITC remained almost free, suggesting the absence of a direct reaction between hITC and SM.
Bacterial strains used were E. coli IFO 3972 and C, which were from laboratory stock. E. coli strains were cultured in either M9 (M9 minimal salts, 5x (Difco): 11.3 g W l; 20z glucose: 20 ml W l; 1 M MgSO 4 : 2 mlW l; 1 M CaCl2: 0.1 mlW l; pH 6.8), or NB (Difco, pH 6.8).
Antimicrobial assay: A system using microplate 96 ‰at-bottomed wells was previously described. 3) Serially diluted solutions of hITC (10 ml) dissolved in 50z dimethyl sulfoxide were put into each well of the microplate. After overnight incubation at 37ﾟC bacterial cultures were diluted with each medium to make suspensions of 6-9×10 6 cells W ml, and 80 ml of which was then added to each well containing ITC solution. After incubation at 37ﾟC for 20 min, 10 ml of antibiotic solutions (at various concentrations) were added to the wells. Then, the microplates were sealed with tape and placed in an incubator at 37ﾟC for 24 h. The growth of bacteria was monitored by measuring the turbidity at 660 nm, with a microplate reader (Molecular Devise; model SPECTRAmax 190). The growth was expressed as the relative value (z) which represented the ratio of growth with antibiotic and W or hITC to that of the control without them. The turbidity of the control was taken as 100z.
Bactericidal assay: An overnight culture was centrifuged at 6000 rpm for 10 min and the cells were washed with physiological saline. Then, parts (2.8 ml) of the cell suspension, which was adjusted to about 3×10 6 cells W ml with physiological saline containing 4 g W l of glucose and 100 ml of SM aqueous solution (0 and 0.3 mg W ml), were put into sterile test tubes. Serially diluted solutions of hITC (100 ml) dissolved in dimethyl sulfoxide were added 20 min before (-20 min), simultaneously with (0 min), or 15 or 30 min after the addition of SM, respectively. After incubation at 37ﾟC, 80 spm for 2 hours, the number of surviving cells (CFU) was measured by a conventional method.
The eŠects of hITC on the growth of E. coli IFO 3972 and C in M9 in the presence or absence of SM are shown in Fig. 1 (A, B) . As we reported previously, 3) combined use of 1 mg W ml of SM and 30-40 mg W ml of hITC had a synergetic growth-inhibiting eŠect. On the other hand, when the concentration of SM was increased to 2 mg W ml, the antibacterial eŠect of SM was markedly reduced by hITC, at a range of 1 to 10 mg W ml. Although a single use of hITC (5 mg W ml) and SM (2 mg W ml) caused about 0z and 85z inhibition respectively, the growth inhibition of E. coli IFO 3972 was diminished to only 5z by the combined use of the two compounds. At the hITC concentrations higher than 10 mg W ml, its antibacterial activity surpassed the suppressive eŠect. A similar synergistic eŠect and suppression of antibacterial activity between SM and hITC were observed on E. coli C as well. This synergistic antimicrobial activity with hITC is speciˆc for aminoglycoside antibiotics, as mentioned before.
3) However, such suppression of antimicrobial activity by hITC was observed not only on aminoglycoside antibiotics such as SM, kanamycin, or ribostamycin, but also on chloramphenicol or nalidixic acid, to some extent (data not shown). These results suggest that the mechanism of the suppression of SM by hITC might be diŠerent from that of the synergism. In order to know whether the observed suppression is due to a possible block by hITC of cellular permeation or uptake of antibiotics, experiments were repeated using E. coli IFO3972 treated with 1 mM EDTA. No signiˆcant diŠerence was, however, detected between EDTA-treated cells and the untreated control, in the synergism and the suppression of antibiotic activity (data not shown). Figure 2 (A-D) shows the eŠects of the addition time of hITC on the bactericidal activity of SM to E. coli. The bactericidal activity of SM was reduced, when hITC had been administered at 20 min before the addition of SM (Fig. 2 (A) ): the bactericidal activity of SM was almost nulliˆed by adding 20 mg W ml of hITC at this time, whereas the suppression of SM by hITC was weakened with delay of addition time, (15-30 min after SM). These results indicate that hITC exerts its suppressive action on SM at an early particular stage.
These data presented above demonstrate that both the concentrations of hITC and SM are crucial in their combined use for inhibition of bacterial growth. Indeed a small change in their concentrations aŠects their actions strangely, for example, from synergism to suppression. The suppression of antibacterial activity was more notable in M9 than in nutrient broth (data not shown). Although this result suggests involvement of medium component(s) such as glucose, the mechanism of the peculiar suppression of SM by hITC, like that of the synergism, is still unclear. The concentration-dependent dual action of hITC on SM is suggestive of two diŠerent targets. It seems not improbable that hITC inhibits, at lower concentrations, an in‰ux across the outer membrane, and at higher concentrations, eOEux through the inner membrane, of SM. As hITC is similarly antagonistic, but not synergistic, with chloramphenicol or nalidixic acid, a common outer membrane protein such as polin might be involved in penetration of these compounds. Like hITC, parachloromercuribenzoate (0.2-0.6 mg W ml) had synergistic antibacterial eŠects with SM, on E. coli. The sulfhydryl blocking agent, however, did not suppress SM action (unpublished observation). Nevertheless, these phenomena, at present observed only in this in vitro system, might be encountered upon administration of certain medicines to humans after taking natural ITCs in vegetables.
